Nesina

alogliptin · Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Nesina, covering 2011-02-24 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: DPP4-Inhibitors and Bone Metabolism in Diabetes [Phase 3]